StockData
Health Catalyst, Inc. logo

Health Catalyst, Inc. (HCAT) stock

HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3075% below fair value
$1.37−0.01 (-0.72%)

Close on Nov 17, 2026Market cap $103.10MP/E –Yield –

Health Catalyst r&d expenses

Research and development expenses are spending on new products and technology.

Health Catalyst's R&D Expenses for the twelve months ending Jun 30, 2026 was $43.00M, down 24.3% year over year. For fiscal 2025 it was $49.77M, down 14.1% from the year before. The highest annual figure on record is $75.68M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$49.77M-14.1%
FY2024Dec 31, 2024$57.95M-20.2%
FY2023Dec 31, 2023$72.63M-4.0%
FY2022Dec 31, 2022$75.68M+20.6%
FY2021Dec 31, 2021$62.73M+17.2%
FY2020Dec 31, 2020$53.52M+15.7%
FY2019Dec 31, 2019$46.25M+19.8%
FY2018Dec 31, 2018$38.59M+35.6%
FY2017Dec 31, 2017$28.47M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.03M-11.0%
Q1 FY2026Mar 31, 2026$9.78M-35.6%
Q4 FY2025Dec 31, 2025$9.91M-33.9%
Q3 FY2025Sep 30, 2025$12.28M-13.5%
Q2 FY2025Jun 30, 2025$12.39M-10.7%
Q1 FY2025Mar 31, 2025$15.19M+2.1%
Q4 FY2024Dec 31, 2024$15.00M-26.1%
Q3 FY2024Sep 30, 2024$14.19M-19.7%
Q2 FY2024Jun 30, 2024$13.88M-21.1%
Q1 FY2024Mar 31, 2024$14.87M-12.9%
Q4 FY2023Dec 31, 2023$20.29M+3.4%
Q3 FY2023Sep 30, 2023$17.67M-14.9%
Q2 FY2023Jun 30, 2023$17.59M-3.1%
Q1 FY2023Mar 31, 2023$17.08M-0.4%
Q4 FY2022Dec 31, 2022$19.61M+12.2%
Q3 FY2022Sep 30, 2022$20.77M+26.8%
Q2 FY2022Jun 30, 2022$18.15M+25.0%
Q1 FY2022Mar 31, 2022$17.15M+19.5%
Q4 FY2021Dec 31, 2021$17.48M+16.7%
Q3 FY2021Sep 30, 2021$16.39M+22.4%
Q2 FY2021Jun 30, 2021$14.52M+20.4%
Q1 FY2021Mar 31, 2021$14.35M+9.6%
Q4 FY2020Dec 31, 2020$14.98M+14.8%
Q3 FY2020Sep 30, 2020$13.39M-0.6%
Q2 FY2020Jun 30, 2020$12.06M+24.2%
Q1 FY2020Mar 31, 2020$13.09M+30.6%
Q4 FY2019Dec 31, 2019$13.04M+23.5%
Q3 FY2019Sep 30, 2019$13.48M+24.3%
Q2 FY2019Jun 30, 2019$9.71M+14.4%
Q1 FY2019Mar 31, 2019$10.02M–
Q4 FY2018Dec 31, 2018$10.56M–
Q3 FY2018Sep 30, 2018$10.84M–
Q2 FY2018Jun 30, 2018$8.49M–

More Health Catalyst figures

See a number that looks wrong?